Gottfrid Sjödahl
21 – 30 of 71
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Diagnostic and prognostic implications of a three-antibody molecular subtyping algorithm for non-muscle invasive bladder cancer
- Contribution to journal › Article
-
Mark
A quantitative polymerase chain reaction based method for molecular subtype classification of urinary bladder cancer—Stromal gene expressions show higher prognostic values than intrinsic tumor genes
- Contribution to journal › Article
-
Mark
Complete metabolic response with [18F]fluorodeoxyglucose-positron emission tomography/computed tomography predicts survival following induction chemotherapy and radical cystectomy in clinically lymph node positive bladder cancer
- Contribution to journal › Article
-
Mark
The Lund Molecular Taxonomy Applied to Non-Muscle-Invasive Urothelial Carcinoma
- Contribution to journal › Article
-
Mark
The Urothelial Transcriptomic Response to Interferon Gamma : Implications for Bladder Cancer Prognosis and Immunotherapy
- Contribution to journal › Article
-
Mark
Molecular Subtypes as a Basis for Stratified Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer—A Narrative Review
- Contribution to journal › Scientific review
-
Mark
Immunohistochemistry subtyping of urothelial carcinoma is feasible in the daily practice
- Contribution to journal › Article
- 2021
-
Mark
When the Molecular Subtype Is Hidden Behind a Veil of Stroma
- Contribution to journal › Debate/Note/Editorial
-
Mark
Tumor Subtyping : Making Sense of Heterogeneity with a Goal Toward Treatment
- Contribution to journal › Scientific review
-
Mark
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
- Contribution to journal › Article
